Population based assessment of HER-2 and PD-L1 positivity in gastric and gastroesophageal junction adenocarcinomas in a Canadian population.
Patrick L. Holland(Yale University), Stephanie Snow(Dalhousie University), Rumana Rafiq(Institute of Cancer Research), Thomas Arnason(Dalhousie University), Myuran Thana(Queen Elizabeth II Health Sciences Centre), Ashley Stueck(Dalhousie University), Heidi Sapp(Queen Elizabeth II Health Sciences Centre), Phillip Moss(Queen Elizabeth II Health Sciences Centre), Kara Matheson(Nova Scotia Health Authority), Kelly Dakin-Haché(Queen Elizabeth II Health Sciences Centre)
Cited by 0
Related Papers
ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
|Nature Communications|2016|386
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
|Cancer Research|2013|367
cHCC‐CCA
|Hepatology|2018|333
Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
|Oncotarget|2015|201
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
|Thrombosis Research|2005|194